SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • February 4th, 2022 • Exicure, Inc. • Pharmaceutical preparations • Illinois
THIS SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the "Agreement") is entered into as of January 26, 2022, by and between Exicure, Inc., a Delaware corporation (the "Company"), and Matthias Schroff, Ph.D. ("Executive") (each of the Executive and the Company, a "Party," and collectively, the "Parties"), amends and restates in its entirety the Amended and Restated Employment Agreement between the Parties effective as of December 10, 2019 (the “Executive Agreement”), that certain side letter agreement between the Parties dated June 9, 2020 (the “Side Letter”), and that certain Second Amendment to the Amended and Restated Employment Agreement between the Parties effective December 10, 2021 (the “Amendment” and together with the Executive Agreement and the Side Letter collectively, the “Prior Agreements”). This Agreement is effective as of February 4, 2022 (the "Effective Date").
Separation and Transition AgreementSeparation and Transition Agreement • February 4th, 2022 • Exicure, Inc. • Pharmaceutical preparations • Illinois
This Separation and Transition Agreement (the “Agreement”) is made and entered into by and between Exicure, Inc. (the “Company”), and David A. Giljohann, Ph.D., an individual (“Employee,” “Giljohann” or “you”).
ADVISOR AGREEMENTAdvisor Agreement • February 4th, 2022 • Exicure, Inc. • Pharmaceutical preparations • Illinois
This Advisor Agreement (the “Agreement”) is entered into by and between Exicure, Inc. (the “Company”) and Brian C. Bock, an individual (“Advisor”) (each of the Advisor and the Company, a “Party,” and collectively, the “Parties”) is effective as of February 4, 2022 (the “Effective Date”).
